Strategic Partnerships Allergan has a history of collaboration and acquisitions, including its 2020 AbbVie acquisition and ongoing legal/commercial interactions in the aesthetics and eye care spaces. Target potential partners or channel collaborations with contract manufacturers, distributors, or research networks to expand product reach and co-develop eye care and aesthetic solutions.

Aesthetic Leadership Recent product launches and trends point to ongoing demand in aesthetics, such as Latisse and the Future of Aesthetics Global Trends Report. Focus on opportunities to supply complementary devices, marketing analytics, or consumer insight platforms that enhance product differentiation and consumer engagement.

Regulatory Vigilance There has been regulatory activity surrounding implants and surgical products, including recalls. This signals a need for robust quality assurance, regulatory compliance solutions, and post-market surveillance offerings that can help maintain trust and minimize risk for clinics and manufacturers.

Tech Enablement Allergan’s tech stack includes cloud platforms, analytics, and tracking tools. There is an opportunity to propose modern digital adoption services, cloud-native product analytics, user behavior insights, and secure deployment of clinical or customer-facing applications to optimize manufacturing and patient outcomes.

Global Reach With a revenue range of 1B to 10B and a sizable employee base, Allergan operates across multiple markets, suggesting sales opportunities in regionalization services, supply chain optimization, and localized marketing intelligence to support scale and compliance across geographies.